Project Grant HT94252510832
- Federal Grant Award Summary The Veterans Medical Research Foundation of San Diego received a $4.8 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. This award funds a hybrid Type I evaluation of integrative health care interventions for Post-Traumatic Stress Disorder (PTSD), combining rigorous clinical trial methodology with implementation...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $2.35M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded July 1, 2025, with a completion date of June 30, 2029. This award funds research to evaluate a technology-enhanced, entirely remote two-week integrated treatment protocol that combines neuromodulation with prolonged exposure therapy to address both pain and...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $3.15 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with completion targeted for September 29, 2029. This clinical research award supports a randomized controlled trial investigating the efficacy of noninvasive brain stimulation combined with written exposure therapy as a treatment...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Veterans Medical Research Foundation of San Diego a $2,074,865 Project Grant effective September 1, 2025, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award funds research to develop machine learning algorithms that utilize pre-intervention supraspinal functional connectivity imaging data to predict patient responsiveness to repetitive transcranial magnetic stimulation...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) a Project Grant totaling $1,499,912 under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025, through May 31, 2028. The primary deliverable under this award is a clinical research study investigating the safety, tolerability, and outcomes of psilocybin treatment in veterans with spinal cord injury. This research...
- Federal Grant Award Summary Northern California Institute For Research And Education, Inc. (NCIRE) received a $2.95 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025. The grant supports a four-year research initiative examining Suvorexant, an orexin-targeting pharmaceutical agent, as an augmentation therapy to exposure therapy for veterans with post-traumatic stress disorder (PTSD) and comorbid...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Tampa VA Research and Education Foundation, Inc. a $639,831 project grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The grant supports a randomized clinical trial focused on reducing aggression in military personnel. The research will be conducted at the foundation's facility in Temple Terrace, Florida, and represents part of the...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...
The Defense Health Agency (DHA) awarded $2.48M to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, to conduct a Phase 2A randomized controlled clinical trial evaluating the efficacy and safety of PT150 in treating posttraumatic stress disorder (PTSD) in U.S. military veterans. The four-year project, scheduled for completion on September 29, 2029, will be conducted at multiple Veterans Affairs (VA) medical centers, with research activities coordinated across sites to assess PT150's effectiveness in reducing PTSD symptoms, evaluate safety and tolerability, and explore secondary benefits in reducing alcohol use and enhancing fear extinction. The study will include structured recruitment protocols with emphasis on minority enrollment, informed consent procedures, data integrity management in coordination with a Data Safety Monitoring Board, and peer-reviewed publication of results. Baylor College of Medicine serves as a sub-awardee under the project with specific operational responsibility for the Houston VA site. Dr. Verrico will serve as the Houston site principal investigator, supervising research staff, managing participant recruitment and enrollment, coordinating study harmonization with the lead investigator at San Diego VA, and ensuring compliance with institutional review board, VA Research and Development, and federal regulatory requirements. The sub-award was issued on February 19, 2026, and includes oversight of hypothesis development, experimental design, data acquisition, statistical analysis, and collaborative reporting of clinical trial outcomes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 7/17/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
BMC104190000329366S | Baylor College Of Medicine | Project Grant HT94252510832 | $1.0m | 2/20/26 |